Adverse effects of GLP-1 receptor agonists: difference between revisions
Diff·revision 32 → 33·18:53, 3 Nov 2025
Difference between revision 32 and revision 33 of Adverse effects of GLP-1 receptor agonists. This revision changed no lines of source — the edit was a null or whitespace change.
| Revision 32 — 04:57, 11 Oct 2025 ParentCatPansy (talk) expand §Less common but significant 5,791 bytes ±0 | Revision 33 — 18:53, 3 Nov 2025 RegainRomilly (talk) rm the comparison with a compound that has no comparable safety dataset 5,791 bytes ±0 | ||
|---|---|---|---|
| — | No change to the page source. | — |